Semaglutide antidiabetic drug action, illustration
Illustration of semaglutide (blue, red and grey spheres) bound to a glucagon-like peptide-1 (GLP-1) transmembrane receptor (multi-coloured 3D structure across membrane). A G protein, part of the GLP-1 signalling cascade, is visible below the membrane (rounded multicoloured structure). Semaglutide is a GLP-1 receptor agonist, a type of drug that mimics the function of natural GLP-1 hormones. GLP-1 hormones are released in the gastrointestinal tract when we eat. They work by binding to GLP-1 receptors throughout the body and stimulating insulin secretion, inhibiting glucagon secretion, and slowing down gastric emptying. These effects all lower blood sugar levels, making semaglutide a treatment option for type 2 diabetes. Semaglutide is the active ingredient in Ozempic, a drug used to treat diabetes.
Size: 3520px × 4977px
Location:
Photo credit: © RAMON ANDRADE 3DCIENCIA/SCIENCE PHOTO LIBRARY / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: -, 2, 3, 3d, action, agonist, antidiabetic, artwork, bilayer, binding, biochemical, biochemistry, biological, biology, blood, bound, cascade, cell, cgi, control, diabetes, digitally, dimensional, drug, endocrine, endocrinological, endocrinology, generated, glp-1, glucagon-, glycaemic, glycemic, gs, healthcare, hormone, illustration, loss, mechanism, medical, medication, medicine, membrane, molecular, ozempic, peptide-1, peptides, pharma, pharmaceutical, pharmaceuticals, pharmacological, pharmacology, phospholipid, plasma, protein, proteins, receptor, rybelsus, semaglutide, signalling, structure, sugar, system, transmembrane, treatment, type, wegovy, weight
